Taxol-induced p34(cdc2) kinase activation and apoptosis inhibited by 12- O-Tetradecanoylphorbol-13-acetate in human breast MCF-7 carcinoma cells

Cell Growth and Differentiation

Volumn 9, Issue 1, 1998, Pages 23-29

  Shen, Shing Chuan ^a   Huang, Tze Sing ^b   Jee, Shiou Hwa ^a   Kuo, Min Lang ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CYCLIN A; CYCLIN B; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PACLITAXEL; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE; PROTEIN KINASE C; PROTEIN SERINE THREONINE KINASE; ANTINEOPLASTIC AGENT; CYCLIN DEPENDENT KINASE 1;

APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MICROTUBULE ASSEMBLY; MITOSIS; PRIORITY JOURNAL; BREAST TUMOR; CELL CULTURE; DRUG EFFECT; ENZYMOLOGY; METABOLISM; PATHOLOGY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BREAST NEOPLASMS; CDC2 PROTEIN KINASE; ENZYME ACTIVATION; HUMANS; PACLITAXEL; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED;

EID: 0031594782     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Sarosy. G., and Reed, E. Taxol dose intensification and its clinical implications. J. Natl. Med. Assoc., 85: 427-431, 1993.
2. Rowinsky, E. K. Update on the antitumor activity of paclitaxel in clinical trials. Ann. Phamnacother., 28: S18-S22, 1994.
3. Kumar, N. Taxol-induced polymerization of purified tubulin. Mechanism of action. J. Biol. Chem., 256: 10435-10441, 1981.
4. Roberts, J. R., Allison, D. C., Donehower, R. C., and Rowinsky, E. K. Development of polyploidization in Taxol-resistant human leukemia cells in vitro. Cancer Res., 50: 710-716, 1990.
5. Horwitz, S. B. Mechanism of action of Taxol. Trends Pharmacol. Sci., 73: 134-136, 1992.
6. Nurse, P. Universal control mechanism regulating onset of M-phase. Nature (Lond.), 344: 503-508, 1990.
7. Nigg, E. A. Targets of cyclin-dependent protein kinases. Curr. Opin. Cell Biol., 5: 187-193, 1993.
8. Solomon, M. J. Activation of the various cyclin/cdc2 protein kinases. Curr. Opin. Cell Biol., 5: 180-186, 1993.
9. Gallant, P., and Nigg, E. A. Cyclin B2 undergoes cell cycle-dependent nuclear translation, and when expressed as a non-destructible mutant, causes mitotic arrest in HeLa cells. J. Cell Biol., 117: 213-224, 1992.
10. Lorca, T., Labbé, J. C., Devault, A., Fesquet, D., Capony, J. P., Cavadore, J. C., Le Bouffant, F., and Doree, M. Dephospnorylatkxi of Cdc2 on Thr-161 is required for cdc2 kinase inactivation and normal anaphase. EMBO J. 11: 2381-2390, 1992.
11. cdc2 activation required for apoptosis. Science (Washington DC), 263:1143-1145, 1994.
12. Shimizu, T., O'Connor, P. M., Kohn, K. W., and Pommier, Y. Unscheduled activation of cyclin B1/cdc2 kinase in human promyelocytic leukemia cell line HL-60 cells undergoing apoptosis induced by DMA damage. Cancer Res., 55: 228-231, 1995.
13. cdc2 coincident with Taxol-induced apoptosis. Cell Growth Differ., 5: 1041-1050, 1994.
14. Magnelli, L., Cinelli, M., and Chiarugi, V. Phorbol esters attenuate the expression of p53 in cells treated with doxorubicin and protect TS-p53/ K562 from apoptosis. Biochem. Biophys. Res. Commun., 215: 641-645, 1995.
15. Day, M. L, Zhao, X., Wu, S., Swanson, P. E., and Humphrey, P. A. Phorbol ester-induced apoptosis is accompanied by NGF 1-A and c-fos activation in androgen-sensitive prostate cancer cells. Cell Growth Differ. 5: 735-741, 1994.
16. Solary, E., Bertrand, R., and Pommier, Y. Apoptosis of human leukemic HL-60 cells induced to differentiate by phorbol ester treatment. Leukemia (Baltimore), 8: 792-797, 1994.
17. 2 phase to mitosis in synchronized HeLa cells. Exp. Cell Res., 212: 383-388, 1994
18. Vesely, J., Havlicek, L., Strnad. M., Blow, J. J., and Meizer, L. Inhibition of cyclin-dependent kinase by purine analogues. Eur. J. Biochem., 224:771-786, 1994.
19. Shu, C. H., Yang, W. K., and Huang, T. S. Increased cyclin B1/CDC2 kinase activity and phosphorylation of Bcl-2 associated with paclitaxelinduced apoptosis in human nasopharyngeal carcinoma cells. Apoptosis, 1: 141-146, 1996.
20. Meikrantz, W., Gisselbrecht, S., Tarn, S. W., and Schlegel, R. Activation of cyclin A-dependent protein kinases during apoptosis. Proc. Natl. Acad, Sci USA, 97: 3754-3758, 1994.
21. cdc2 kinases for apoptosis mediated by the Fas/Apo-1 receptor and interteukin 1 β-converting enzyme-related protease. Cancer Res., 56: 4551-4555, 1996.
22. cdc2 and apoptosis. Science (Washington DC), 269:106-107, 1995.
23. Zhu, W. H., and Loh, T. T. Differential effects of phorbol ester on apoptosis in HL-60 promyelocytic leukemia cells. Biochem. Pharmacol. 57: 1229-1236, 1996.
24. Galaklionov, K., Jessus, C., and Beach, D. Raf 1 interaction with Cdc25 phosphatase lies mitogenic signal transduction to cell cycle transduction. Genes Dev., 9: 1046-1058, 1995.
25. Conklin, D. S., Galaktionov, K., and Beach, D. 14-3-3 proteins associated with cdc25 phosphatase. Proc. Natl. Acad. Sci. USA, 92: 7892-7896, 1995.
26. Crossin, K. L, and Camay, D. H. Microtubule stabilization by Taxol inhibits initiation of DMA synthesis by thrombus and epidermal growth factor. Cell. 27: 341-350, 1981.
27. Jordan, M. A., Toso, R. J., Thrower, D., and Wilson, L. Mechanism of mitotic block and inhibition of cell proliferation by Taxd at low concentrations. Proc. Natl. Acad. Sci. USA, 90: 9552-9556, 1993.
28. Seiter, K., Feldman, E. J., and Traganos, F. Evaluation of acute leukemia treated on a Phase I study with paclitaxel. Leukemia (Baltimore), 9: 1961-1966, 1995.
29. Donaldson, K. L., Goolsby, G. L., and Wshl, A. F. Cytotoxicity of the anticancer agents cisplatin and Taxol during cell proliferation and the cell cycle. Int. J. Cancer, 57: 847-855, 1994.
30. Halicka, H. D., Seiter, K., Feldman, E. J., Traganos, F., Mittelman, A., Ahmed, T., and Darzynkiewicz, Z. Cell cycle specificity of apoptosis during treatment of leukemias. Apoptosis, 2: 25-39, 1997.
31. 2/M arrest and activation of cyclin-dependent kinases associated with low-dose paclitaxel-induced sub-G, apoptosis. Apoptosis, in press, 1997.
32. Sumantran, V. N., Ealovega, M. W., Nunez, G., Clarke, M. F., and Wicha, M. S. Overexpression of Bcl-Xs sensitizes MCF-7 cells to chemotherapy-induced apoptosis. Cancer Res., 55: 2507-2510, 1995.
33. 1 pathways. Proc. Natl. Acad. Sci. USA, 92: 4793-4797, 1995.
34. waf1 and p53 requires c-raf-1. Cancer Res., 55: 4623-4626, 1995.
35. Enari, M., Hug, H., and Nagata, S. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature (Lond.), 375: 78-81, 1995.